Selected research
Industry Research
Nasal Drug Delivery Technology Industry Research Report 2026
Market perspective
The global Nasal Drug Delivery Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nasal Drug Delivery Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nasal Drug Delivery Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nasal Drug Delivery Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nasal Drug Delivery Technology include Johnson & Johnson, Novartis AG, Merck & Co., Inc., Pfizer, Inc, Shin Nippon Biomedical Laboratories, Promius Pharma, LLC, PendoPharm, Inc, OptiNose, Inc and Glaxosmithkline PLC, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nasal Drug Delivery Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nasal Drug Delivery Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nasal Drug Delivery Technology Market by Company
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
Pfizer, Inc
Shin Nippon Biomedical Laboratories
Promius Pharma, LLC
PendoPharm, Inc
OptiNose, Inc
Glaxosmithkline PLC
ENT Technologies Pty. Ltd
Douglas Pharmaceuticals Ltd
Dickinson and Company
Cadila Pharmaceuticals Ltd
BF Ascher & Company, Inc.
Becton, Dickinson and Company
Aptargroup, Inc.
Aegis Therapeutics LLC
3M United States
Nasal Drug Delivery Technology Segment by Type
Pressurized Type
Non-pressurized Type
Nasal Drug Delivery Technology Segment by Application
Asthma
Rhinitis
Nasal Congestion
Other
Nasal Drug Delivery Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Drug Delivery Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nasal Drug Delivery Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Drug Delivery Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nasal Drug Delivery Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pressurized Type
- Non-pressurized Type
Applications
- Asthma
- Rhinitis
- Nasal Congestion
- Other
Companies covered
- Johnson & Johnson
- Novartis AG
- Merck & Co., Inc.
- Pfizer, Inc
- Shin Nippon Biomedical Laboratories
- Promius Pharma, LLC
- PendoPharm, Inc
- OptiNose, Inc
- Glaxosmithkline PLC
- ENT Technologies Pty. Ltd
- Douglas Pharmaceuticals Ltd
- Dickinson and Company
- Cadila Pharmaceuticals Ltd
- BF Ascher & Company, Inc.
- Becton, Dickinson and Company
- Aptargroup, Inc.
- Aegis Therapeutics LLC
- 3M United States
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nasal Drug Delivery Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pressurized Type
- 2.2.3 Non-pressurized Type
- 2.3 Nasal Drug Delivery Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Asthma
- 2.3.3 Rhinitis
- 2.3.4 Nasal Congestion
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Nasal Drug Delivery Technology Breakdown Data by Type
- 3.1 Global Nasal Drug Delivery Technology Historic Market Size by Type (2021-2026)
- 3.2 Global Nasal Drug Delivery Technology Forecasted Market Size by Type (2027-2032)
4 Nasal Drug Delivery Technology Breakdown Data by Application
- 4.1 Global Nasal Drug Delivery Technology Historic Market Size by Application (2021-2026)
- 4.2 Global Nasal Drug Delivery Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nasal Drug Delivery Technology Market Perspective (2021-2032)
- 5.2 Global Nasal Drug Delivery Technology Growth Trends by Region
- 5.2.1 Global Nasal Drug Delivery Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nasal Drug Delivery Technology Historic Market Size by Region (2021-2026)
- 5.2.3 Nasal Drug Delivery Technology Forecasted Market Size by Region (2027-2032)
- 5.3 Nasal Drug Delivery Technology Market Dynamics
- 5.3.1 Nasal Drug Delivery Technology Industry Trends
- 5.3.2 Nasal Drug Delivery Technology Market Drivers
- 5.3.3 Nasal Drug Delivery Technology Market Challenges
- 5.3.4 Nasal Drug Delivery Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nasal Drug Delivery Technology Players by Revenue
- 6.1.1 Global Top Nasal Drug Delivery Technology Players by Revenue (2021-2026)
- 6.1.2 Global Nasal Drug Delivery Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global Nasal Drug Delivery Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nasal Drug Delivery Technology Head Office and Area Served
- 6.4 Global Nasal Drug Delivery Technology Players, Product Type & Application
- 6.5 Global Nasal Drug Delivery Technology Manufacturers Established Date
- 6.6 Global Nasal Drug Delivery Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nasal Drug Delivery Technology Market Size (2021-2032)
- 7.2 North America Nasal Drug Delivery Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nasal Drug Delivery Technology Market Size by Country (2021-2026)
- 7.4 North America Nasal Drug Delivery Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nasal Drug Delivery Technology Market Size (2021-2032)
- 8.2 Europe Nasal Drug Delivery Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nasal Drug Delivery Technology Market Size by Country (2021-2026)
- 8.4 Europe Nasal Drug Delivery Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nasal Drug Delivery Technology Market Size (2021-2032)
- 9.2 Asia-Pacific Nasal Drug Delivery Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nasal Drug Delivery Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nasal Drug Delivery Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nasal Drug Delivery Technology Market Size (2021-2032)
- 10.2 South America Nasal Drug Delivery Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nasal Drug Delivery Technology Market Size by Country (2021-2026)
- 10.4 South America Nasal Drug Delivery Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nasal Drug Delivery Technology Market Size (2021-2032)
- 11.2 Middle East & Africa Nasal Drug Delivery Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.1.4 Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 Novartis AG
- 12.2.1 Novartis AG Company Information
- 12.2.2 Novartis AG Business Overview
- 12.2.3 Novartis AG Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.2.4 Novartis AG Nasal Drug Delivery Technology Product Portfolio
- 12.2.5 Novartis AG Recent Developments
- 12.3 Merck & Co., Inc.
- 12.3.1 Merck & Co., Inc. Company Information
- 12.3.2 Merck & Co., Inc. Business Overview
- 12.3.3 Merck & Co., Inc. Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.3.4 Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio
- 12.3.5 Merck & Co., Inc. Recent Developments
- 12.4 Pfizer, Inc
- 12.4.1 Pfizer, Inc Company Information
- 12.4.2 Pfizer, Inc Business Overview
- 12.4.3 Pfizer, Inc Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.4.4 Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio
- 12.4.5 Pfizer, Inc Recent Developments
- 12.5 Shin Nippon Biomedical Laboratories
- 12.5.1 Shin Nippon Biomedical Laboratories Company Information
- 12.5.2 Shin Nippon Biomedical Laboratories Business Overview
- 12.5.3 Shin Nippon Biomedical Laboratories Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.5.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio
- 12.5.5 Shin Nippon Biomedical Laboratories Recent Developments
- 12.6 Promius Pharma, LLC
- 12.6.1 Promius Pharma, LLC Company Information
- 12.6.2 Promius Pharma, LLC Business Overview
- 12.6.3 Promius Pharma, LLC Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.6.4 Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio
- 12.6.5 Promius Pharma, LLC Recent Developments
- 12.7 PendoPharm, Inc
- 12.7.1 PendoPharm, Inc Company Information
- 12.7.2 PendoPharm, Inc Business Overview
- 12.7.3 PendoPharm, Inc Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.7.4 PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio
- 12.7.5 PendoPharm, Inc Recent Developments
- 12.8 OptiNose, Inc
- 12.8.1 OptiNose, Inc Company Information
- 12.8.2 OptiNose, Inc Business Overview
- 12.8.3 OptiNose, Inc Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.8.4 OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio
- 12.8.5 OptiNose, Inc Recent Developments
- 12.9 Glaxosmithkline PLC
- 12.9.1 Glaxosmithkline PLC Company Information
- 12.9.2 Glaxosmithkline PLC Business Overview
- 12.9.3 Glaxosmithkline PLC Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.9.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio
- 12.9.5 Glaxosmithkline PLC Recent Developments
- 12.10 ENT Technologies Pty. Ltd
- 12.10.1 ENT Technologies Pty. Ltd Company Information
- 12.10.2 ENT Technologies Pty. Ltd Business Overview
- 12.10.3 ENT Technologies Pty. Ltd Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.10.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio
- 12.10.5 ENT Technologies Pty. Ltd Recent Developments
- 12.11 Douglas Pharmaceuticals Ltd
- 12.11.1 Douglas Pharmaceuticals Ltd Company Information
- 12.11.2 Douglas Pharmaceuticals Ltd Business Overview
- 12.11.3 Douglas Pharmaceuticals Ltd Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.11.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
- 12.11.5 Douglas Pharmaceuticals Ltd Recent Developments
- 12.12 Dickinson and Company
- 12.12.1 Dickinson and Company Company Information
- 12.12.2 Dickinson and Company Business Overview
- 12.12.3 Dickinson and Company Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.12.4 Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
- 12.12.5 Dickinson and Company Recent Developments
- 12.13 Cadila Pharmaceuticals Ltd
- 12.13.1 Cadila Pharmaceuticals Ltd Company Information
- 12.13.2 Cadila Pharmaceuticals Ltd Business Overview
- 12.13.3 Cadila Pharmaceuticals Ltd Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.13.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
- 12.13.5 Cadila Pharmaceuticals Ltd Recent Developments
- 12.14 BF Ascher & Company, Inc.
- 12.14.1 BF Ascher & Company, Inc. Company Information
- 12.14.2 BF Ascher & Company, Inc. Business Overview
- 12.14.3 BF Ascher & Company, Inc. Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.14.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio
- 12.14.5 BF Ascher & Company, Inc. Recent Developments
- 12.15 Becton, Dickinson and Company
- 12.15.1 Becton, Dickinson and Company Company Information
- 12.15.2 Becton, Dickinson and Company Business Overview
- 12.15.3 Becton, Dickinson and Company Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.15.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
- 12.15.5 Becton, Dickinson and Company Recent Developments
- 12.16 Aptargroup, Inc.
- 12.16.1 Aptargroup, Inc. Company Information
- 12.16.2 Aptargroup, Inc. Business Overview
- 12.16.3 Aptargroup, Inc. Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.16.4 Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio
- 12.16.5 Aptargroup, Inc. Recent Developments
- 12.17 Aegis Therapeutics LLC
- 12.17.1 Aegis Therapeutics LLC Company Information
- 12.17.2 Aegis Therapeutics LLC Business Overview
- 12.17.3 Aegis Therapeutics LLC Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.17.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio
- 12.17.5 Aegis Therapeutics LLC Recent Developments
- 12.18 3M United States
- 12.18.1 3M United States Company Information
- 12.18.2 3M United States Business Overview
- 12.18.3 3M United States Revenue in Nasal Drug Delivery Technology Business (2021-2026)
- 12.18.4 3M United States Nasal Drug Delivery Technology Product Portfolio
- 12.18.5 3M United States Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst